CYZB1404722 五酯咀嚼片
3 related IND applications found
2 related NDA applications found
0 related generics applications found
| Application No. | Candidat name | Applicant name | Formulation | Origin | Registration cat. | EphMRA codes/WHO ATC codes | Indication group | CFDA status | CDE opinion | CFDA status (raw data) | CFDA status start date | Days since current status | CDE acceptance date | Days since CDE acceptance |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| JXL1200300 | Pantaprozate 眼剂眼 | Takeda 滴眼国食药剂 剂 | Tablet 滴眼剂 | Import | Chem (unknow) | A02bC03 | Gastroenterology | CDE Review | 0 | 2022-08-13 | 789 | 2022-08-13 | 787 | |
| JXL1200318 | Pantaprozate 眼剂眼 | Takeda 滴眼国食药剂 剂 | Tablet 滴眼剂 | Import | Chem (unknow) | A02bC03 | Gastroenterology | CDE Review | 0 | 2022-08-13 | 789 | 2022-08-13 | 787 | |
| JXL1200499 | Pantaprozate 眼剂眼 | Takeda 滴眼国食药剂 剂 | Tablet 滴眼剂 | Import | Chem (unknow) | A02bC03 | Gastroenterology | CDE Review | 0 | 2022-08-13 | 789 | 2022-08-13 | 787 |
www.gbihealth.com
Suite 301, Building 2, 169 Mengzi Rd.
Shanghai 200023, P.R. China
(8621) 5302 2951
(8621) 5302 2950
CONTACT GBI
© 2014 GB Group Limited. All Rights Reserved.
Terms of Service
Privacy Policy